Gunnel Elisabeth Sunden

Title: Gunnel Elisabeth Sunden: Innovator in Cancer Treatment

Introduction

Gunnel Elisabeth Sunden is a notable inventor based in Sweden. She has made significant contributions to the field of cancer treatment, particularly in the development of innovative therapies for solid tumors. Her work focuses on enhancing the efficacy of chemotherapy through the use of folate alternatives.

Latest Patents

Gunnel has developed several patents aimed at improving cancer treatment. One of her latest inventions is titled "[6R]-Mthf - An Efficient Folate Alternative In 5-Fluorouracil Based Chemotherapy." This invention relates to the treatment of solid tumors in humans, especially colorectal cancer (CRC), by administering the diastereomerically pure folate adjuvant [6R]-5,10-methylenetetrahydrofolate in 5-fluorouracil (5-FU) based chemotherapy. Another significant patent is "[6R]-Mthf Multiple Bolus Administration In 5-Fluorouracil Based Chemotherapy," which also targets the treatment of solid tumors by administering multiple boluses of the same folate adjuvant in 5-FU based chemotherapy.

Career Highlights

Gunnel is currently associated with Isofol Medical AB, a company dedicated to advancing cancer treatment through innovative solutions. Her work at Isofol Medical AB has positioned her as a key player in the field of oncology.

Collaborations

Gunnel has collaborated with notable colleagues, including Per Lennart Lindberg and Bengt Gustavsson. These collaborations have further enhanced her research and development efforts in cancer therapies.

Conclusion

Gunnel Elisabeth Sunden is a pioneering inventor whose work in cancer treatment is making a significant impact. Her innovative approaches to chemotherapy are paving the way for more effective treatments for patients with solid tumors.